The Secretary of Health of the State of Tlaxcala has confirmed the detection of 18 cases of Guillain-Barré syndrome until March 2. This neurological disorder, characterized by muscle weakness and, sometimes, paralysis, has raised concerns in the medical community and the population.
Guillain-Barré Syndrome, also known as GBS, is a rare neurological disorder that causes weakness in the legs, pain in the body, and can sometimes lead to paralysis. The condition is caused by the body’s immune system mistakenly attacking the peripheral nerves, leading to a range of symptoms from mild weakness to severe complications. While the exact cause of GBS is unknown, it is often associated with viral or bacterial infections.
In Tlaxcala, health experts are investigating the cases to better understand the causes of the disease, with a focus on the potential link between GBS and COVID-19. Recent studies have shown a correlation between GBS and COVID-19 in adults, particularly in men and elderly individuals.
Treatment options for Guillain-Barré Syndrome include plasmapheresis and immunoglobulin therapy, which aim to reduce the impact of the immune system’s attack on the peripheral nervous system. The Quick Reference Guide of the Mexican Social Security Institute (IMSS) recommends early intervention with these treatments to improve the chances of a faster and more complete recovery.
It is essential for healthcare professionals to prioritize early detection and treatment of Guillain-Barré Syndrome to mitigate the effects of this debilitating condition. Further research is needed to strengthen the understanding of the connection between GBS and viral infections like COVID-19.